These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38882767)

  • 1. Mesotherapy for Melasma - An Updated Review.
    Kashikar Y; Madke B; Singh A; Meghe S; Rusia K
    J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1055-S1056. PubMed ID: 38882767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of mesotherapy in the treatment of melasma: A review article.
    Khalili M; Amiri R; Iranmanesh B; Zartab H; Aflatoonian M
    J Cosmet Dermatol; 2022 Jan; 21(1):118-129. PubMed ID: 34846788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
    Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
    J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of mesotherapy with tranexamic acid and ascorbic acid with and without glutathione in treatment of melasma: A split face comparative trial.
    Iraji F; Nasimi M; Asilian A; Faghihi G; Mozafarpoor S; Hafezi H
    J Cosmet Dermatol; 2019 Oct; 18(5):1416-1421. PubMed ID: 30735611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
    Patil NK; Bubna AK
    Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of mesotherapy with tranexamic acid versus vitamin C in the treatment of melasma: A meta-analysis and systemic review.
    Liao X; Cheng F; Jiang Y
    J Cosmet Dermatol; 2024 Sep; 23(9):2785-2792. PubMed ID: 38693699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy of Tranexamic Acid Mesotherapy versus 0.9% normal Saline for Melasma; A split face study in a Tertiary Care Hospital of Karachi.
    Kaleem S; Ghafoor R; Khan S
    Pak J Med Sci; 2020; 36(5):930-934. PubMed ID: 32704266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study.
    Karrabi M; Mansournia MA; Sharestanaki E; Abdollahnejad Y; Sahebkar M
    Arch Dermatol Res; 2021 Sep; 313(7):539-547. PubMed ID: 32879998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
    El Hadidi H; Mosaad R; Ragab N
    Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: A comparative study.
    Balevi A; Ustuner P; Özdemir M
    J Cosmet Laser Ther; 2017 Oct; 19(5):294-299. PubMed ID: 28388246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
    Saki N; Darayesh M; Heiran A
    J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of effectiveness of tranexamic acid as mesotherapy in improvement of periorbital wrinkling in a trial study.
    Bazargan AS; Shemshadi M; Ziaeifar E; Taheri A; Roohaninasab M; Goodarzi A; Mirhashemi M
    J Cosmet Dermatol; 2023 Sep; 22(9):2548-2552. PubMed ID: 36987386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
    Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
    J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal tranexamic acid microinjections: a novel treatment option for erythematotelangiectatic rosacea.
    Daadaa N; Litaiem N; Karray M; Bacha T; Jones M; Belajouza Noueiri C; Goucha S; Zeglaoui F
    J Cosmet Dermatol; 2021 Oct; 20(10):3324-3329. PubMed ID: 33973361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal Tranexamic Acid Injection for the Treatment of Melasma: A Pilot Study with 48-week Follow-up.
    Lueangarun S; Sirithanabadeekul P; Wongwicharn P; Namboonlue C; Pacharapakornpong S; Juntongjin P; Tempark T
    J Clin Aesthet Dermatol; 2020 Aug; 13(8):36-39. PubMed ID: 33178380
    [No Abstract]   [Full Text] [Related]  

  • 19. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
    Hawwam SA; Ismail M; El-Attar YA
    Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
    Abd Elraouf IG; Obaid ZM; Fouda I
    Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.